Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 5Active not recruiting 2Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

venetoclax 26Azacitidine 24fludarabine 11Cytarabine 11Specimen Handling 9Biopsy 7Busulfan 6Melphalan 5Decitabine 5Daunorubicin 5Thiotepa 4Cyclophosphamide 4selinexor 3olutasidenib 3gilteritinib 3Whole-Body Irradiation 3Tacrolimus 3Idarubicin 3Homoharringtonine 3treosulfan 2revumenib 2fludarabine phosphate 2decitabine and cedazuridine drug combination 2Stem Cell Transplantation 2Maintenance 2Lymphatic Irradiation 2Leukapheresis 2Injections 2Granulocyte Colony-Stimulating Factor 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Myeloid, Acute × Liposomes × Clear all
NCT05554419 2026-04-13

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
184 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡